FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a new compound of general formula 
or to a pharmaceutically acceptable salt thereof. Besides, the invention refers to pharmaceutical compositions containing a therapeutically effective amount of the above compound or pharmaceutically acceptable salt thereof.
EFFECT: compound of formula IA possesses an inhibitory effect of the sodium-glucose transporter SGLT such that it may be used for treating and/or preventing the conditions and disorders controlled by SGLT activity inhibition.
19 cl, 32 dwg, 2 tbl, 34 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BENZYL DERIVATIVES OF GLYCOSIDES AND METHODS OF THEIR APPLICATION | 2008 |
|
RU2492175C2 |
| CRYSTALLINE FORMS OF COMPLEXES USEFUL AS SGLT2 INHIBITORS, AND METHODS OF THEIR OBTAINING | 2014 |
|
RU2641905C2 |
| METHOD OF OBTAINING SGLT2 BENZYLENBENZOLE INHIBITORS | 2013 |
|
RU2625795C2 |
| COMPOSITIONS COMPRISING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 AND METHODS OF USING THEREOF | 2012 |
|
RU2669921C2 |
| CRYSTALLINE FORM OF BENZYL-BENZENE SGLT INHIBITOR | 2011 |
|
RU2569491C2 |
| BENZYLPHENYLCYCLOHEXANE DERIVATIVES AND METHODS OF THEREOF APPLICATION | 2008 |
|
RU2505521C2 |
| METHOD OF PRODUCING SGLT2 INHIBITORS | 2009 |
|
RU2530494C2 |
| C-GLYCOSIDE DERIVATIVES CONTAINING A CONDENSED PHENYL RING, OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A METHOD OF PRODUCING SUCH AND A PHARMACEUTICAL COMPOSITION CONTAINING SUCH | 2017 |
|
RU2739024C2 |
| C-ARYL GLUCOSIDE DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF | 2011 |
|
RU2606501C2 |
| SOLID FORMS (2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZIL)PHENYL)-6-(METHYLTHIO)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL AND METHODS FOR THEIR OBTAINING | 2009 |
|
RU2505543C2 |
